应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TGTX TG Therapeutics Inc.
盘前交易 07-16 09:11:20 EDT
37.96
-0.96
-2.47%
盘前
38.11
+0.15
+0.40%
09:03 EDT
最高
39.10
最低
37.84
成交量
150.82万
今开
38.99
昨收
38.92
日振幅
3.23%
总市值
60.26亿
流通市值
56.18亿
总股本
1.59亿
成交额
5,765万
换手率
1.02%
流通股本
1.48亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Tg Therapeutics, Inc.5月23日成交额为3579.28万美元
市场透视 · 05-24
Tg Therapeutics, Inc.5月23日成交额为3579.28万美元
Tg Therapeutics, Inc.5月21日成交额为6680.53万美元
市场透视 · 05-22
Tg Therapeutics, Inc.5月21日成交额为6680.53万美元
Tg Therapeutics, Inc.5月20日成交额为5273.47万美元
市场透视 · 05-21
Tg Therapeutics, Inc.5月20日成交额为5273.47万美元
Tg Therapeutics, Inc.5月19日成交额为5319.34万美元
市场透视 · 05-20
Tg Therapeutics, Inc.5月19日成交额为5319.34万美元
Tg Therapeutics, Inc.5月15日成交额为4765.33万美元
市场透视 · 05-16
Tg Therapeutics, Inc.5月15日成交额为4765.33万美元
Tg Therapeutics, Inc.5月14日成交额为5906.79万美元
市场透视 · 05-15
Tg Therapeutics, Inc.5月14日成交额为5906.79万美元
Tg Therapeutics, Inc.2025财年第一财季实现净利润5.06百万美元,同比增加147.25%
市场透视 · 05-12
Tg Therapeutics, Inc.2025财年第一财季实现净利润5.06百万美元,同比增加147.25%
生物制药公司TG Therapeutics股价大跌,Q1盈利不及预期
智通财经网 · 05-05
生物制药公司TG Therapeutics股价大跌,Q1盈利不及预期
生物制药公司TG Therapeutics(TGTX.US)股价大跌 Q1盈利不及预期
智通财经 · 05-05
生物制药公司TG Therapeutics(TGTX.US)股价大跌 Q1盈利不及预期
Tg Therapeutics, Inc.盘中异动 早盘大幅跳水7.80%
市场透视 · 05-05
Tg Therapeutics, Inc.盘中异动 早盘大幅跳水7.80%
Tg Therapeutics, Inc.盘中异动 临近收盘急速下挫5.01%
市场透视 · 05-02
Tg Therapeutics, Inc.盘中异动 临近收盘急速下挫5.01%
Tg Therapeutics, Inc.盘中异动 早盘大幅上涨5.00%报39.89美元
市场透视 · 04-23
Tg Therapeutics, Inc.盘中异动 早盘大幅上涨5.00%报39.89美元
Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元,同比增加84.53%
市场透视 · 03-08
Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元,同比增加84.53%
Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元
市场透视 · 03-06
Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元
Tg Therapeutics, Inc.盘中异动 股价大涨5.00%
市场透视 · 03-04
Tg Therapeutics, Inc.盘中异动 股价大涨5.00%
TG Therapeutics 2024年第四季度GAAP每股收益$0.15,与预期一致,销售额$108.19M超$99.95M预期
财报速递 · 03-03
TG Therapeutics 2024年第四季度GAAP每股收益$0.15,与预期一致,销售额$108.19M超$99.95M预期
Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%
市场透视 · 02-28
Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%
Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%
市场透视 · 02-24
Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%
Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元
市场透视 · 01-31
Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元
Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%
市场透视 · 01-27
Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%
加载更多
公司概况
公司名称:
TG Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司,专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外,TG还获得了美国食品药品监督管理局(FDA)的BRIUMVI(ublituximab-xiiy)批准,用于治疗成人复发性多发性硬化症(RMS)患者,包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。
发行价格:
--
{"stockData":{"symbol":"TGTX","market":"US","secType":"STK","nameCN":"TG Therapeutics Inc.","latestPrice":37.96,"timestamp":1752609600000,"preClose":38.92,"halted":0,"volume":1508175,"hourTrading":{"tag":"盘前","latestPrice":38.11,"preClose":37.96,"latestTime":"09:03 EDT","volume":1366,"amount":52096.498438,"timestamp":1752670991274},"delay":0,"floatShares":148000000,"shares":158755036,"eps":0.238138,"marketStatus":"盘前交易","change":-0.96,"latestTime":"07-16 09:11:20 EDT","open":38.99,"high":39.1,"low":37.842,"amount":57652432.618499994,"amplitude":0.032323,"askPrice":38.19,"askSize":4,"bidPrice":38.11,"bidSize":84,"shortable":3,"etf":0,"ttmEps":0.238138,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752672600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1128657600000,"exchange":"NASDAQ","adjPreClose":37.96,"preHourTrading":{"tag":"盘前","latestPrice":38.11,"preClose":37.96,"latestTime":"09:03 EDT","volume":1366,"amount":52096.498438,"timestamp":1752670991274},"postHourTrading":{"tag":"盘后","latestPrice":37.96,"preClose":37.96,"latestTime":"19:48 EDT","volume":44896,"amount":1704254.91,"timestamp":1752623323159},"volumeRatio":0.9314134361130981,"impliedVol":1.0177,"impliedVolPercentile":0.9679},"requestUrl":"/m/hq/s/TGTX","defaultTab":"news","newsList":[{"id":"2537164595","title":"Tg Therapeutics, Inc.5月23日成交额为3579.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537164595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537164595?lang=zh_cn&edition=full","pubTime":"2025-05-24 12:20","pubTimestamp":1748060445,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日,Tg Therapeutics, Inc.成交额为3579.28万美元,成交额较昨日减少28.33%,当日成交量为104.29万股。Tg Therapeutics, Inc.于2025年5月23日涨0.96%,报34.57美元,该股过去5个交易日涨0.61%,年初至今涨14.85%,过去60日涨21.17%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-23|3579.28万|-28.33%|104.29万|#|2025-05-22|4993.81万|-25.25%|145.80万|#|2025-05-21|6680.53万|26.68%|194.28万|#|2025-05-20|5273.47万|-0.86%|149.35万|#|2025-05-19|5319.34万|-19.59%|154.61万|TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524122051a6eb0398&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524122051a6eb0398&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4539","LENZ","BK4007","BK4139","TGTX","BK4585"],"gpt_icon":0},{"id":"2537998038","title":"Tg Therapeutics, Inc.5月21日成交额为6680.53万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537998038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537998038?lang=zh_cn&edition=full","pubTime":"2025-05-22 12:18","pubTimestamp":1747887506,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日,Tg Therapeutics, Inc.成交额为6680.53万美元,成交额较昨日增加26.68%,当日成交量为194.28万股。Tg Therapeutics, Inc.于2025年5月21日跌3.58%,报34.2美元,该股过去5个交易日涨2.4%,年初至今涨13.62%,过去60日涨17.08%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-21|6680.53万|26.68%|194.28万|#|2025-05-20|5273.47万|-0.86%|149.35万|#|2025-05-19|5319.34万|-19.59%|154.61万|#|2025-05-16|6615.43万|38.82%|193.54万|#|2025-05-15|4765.33万|-19.32%|142.00万|TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522121828a6e8493e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522121828a6e8493e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4585","BK4588","BK4139","LENZ","BK4007","TGTX"],"gpt_icon":0},{"id":"2537672775","title":"Tg Therapeutics, Inc.5月20日成交额为5273.47万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537672775","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537672775?lang=zh_cn&edition=full","pubTime":"2025-05-21 12:08","pubTimestamp":1747800480,"startTime":"0","endTime":"0","summary":"美东时间2025年5月20日,Tg Therapeutics, Inc.成交额为5273.47万美元,成交额较昨日减少0.86%,当日成交量为149.35万股。Tg Therapeutics, Inc.于2025年5月20日涨1.4%,报35.47美元,该股过去5个交易日涨6.29%,年初至今涨17.84%,过去60日涨22.23%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-20|5273.47万|-0.86%|149.35万|#|2025-05-19|5319.34万|-19.59%|154.61万|#|2025-05-16|6615.43万|38.82%|193.54万|#|2025-05-15|4765.33万|-19.32%|142.00万|#|2025-05-14|5906.79万|-57.44%|176.99万|TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521120806a4863031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521120806a4863031&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4007","BK4539","BK4139","LENZ","BK4585","BK4588"],"gpt_icon":0},{"id":"2536664016","title":"Tg Therapeutics, Inc.5月19日成交额为5319.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536664016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536664016?lang=zh_cn&edition=full","pubTime":"2025-05-20 11:54","pubTimestamp":1747713293,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日,Tg Therapeutics, Inc.成交额为5319.34万美元,成交额较昨日减少19.59%,当日成交量为154.61万股。Tg Therapeutics, Inc.于2025年5月19日涨1.8%,报34.98美元,该股过去5个交易日跌0.03%,年初至今涨16.21%,过去60日涨13.28%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-19|5319.34万|-19.59%|154.61万|#|2025-05-16|6615.43万|38.82%|193.54万|#|2025-05-15|4765.33万|-19.32%|142.00万|#|2025-05-14|5906.79万|-57.44%|176.99万|#|2025-05-13|1.39亿|41.80%|415.48万|TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520115502a6e57f72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520115502a6e57f72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","TGTX","BK4539","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2535274337","title":"Tg Therapeutics, Inc.5月15日成交额为4765.33万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535274337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535274337?lang=zh_cn&edition=full","pubTime":"2025-05-16 11:54","pubTimestamp":1747367644,"startTime":"0","endTime":"0","summary":"美东时间2025年5月15日,Tg Therapeutics, Inc.成交额为4765.33万美元,成交额较昨日减少19.32%,当日成交量为142.00万股。Tg Therapeutics, Inc.于2025年5月15日涨0.57%,报33.59美元,该股过去5个交易日跌0.8%,年初至今涨11.59%,过去60日涨8.32%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-15|4765.33万|-19.32%|142.00万|#|2025-05-14|5906.79万|-57.44%|176.99万|#|2025-05-13|1.39亿|41.80%|415.48万|#|2025-05-12|9788.36万|29.53%|283.98万|#|2025-05-09|7556.65万|-38.64%|223.75万|TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516115406a4806214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516115406a4806214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4007","BK4539","BK4585","BK4139","TGTX"],"gpt_icon":0},{"id":"2535720851","title":"Tg Therapeutics, Inc.5月14日成交额为5906.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535720851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535720851?lang=zh_cn&edition=full","pubTime":"2025-05-15 11:45","pubTimestamp":1747280723,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日,Tg Therapeutics, Inc.成交额为5906.79万美元,成交额较昨日减少57.44%,当日成交量为176.99万股。Tg Therapeutics, Inc.于2025年5月14日涨0.09%,报33.4美元,该股过去5个交易日跌4.16%,年初至今涨10.96%,过去60日涨7.19%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-14|5906.79万|-57.44%|176.99万|#|2025-05-13|1.39亿|41.80%|415.48万|#|2025-05-12|9788.36万|29.53%|283.98万|#|2025-05-09|7556.65万|-38.64%|223.75万|#|2025-05-08|1.23亿|-1.23%|362.62万|TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515114531a47f00e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515114531a47f00e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4588","BK4585","TGTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2534229920","title":"Tg Therapeutics, Inc.2025财年第一财季实现净利润5.06百万美元,同比增加147.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534229920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534229920?lang=zh_cn&edition=full","pubTime":"2025-05-12 14:00","pubTimestamp":1747029620,"startTime":"0","endTime":"0","summary":"5月12日,Tg Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为5.06百万美元,同比增加147.25%;其中营业收入为1.21亿美元,同比增加90.64%,每股基本收益为0.03美元。机构评级:截至2025年5月12日,当前有6家机构对Tg Therapeutics, Inc.目标价做出预测,其中目标均价为43.50美元,其中最低目标价为11.00美元,最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512140023a6dbc713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512140023a6dbc713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TGTX"],"gpt_icon":0},{"id":"1124466042","title":"生物制药公司TG Therapeutics股价大跌,Q1盈利不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1124466042","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124466042?lang=zh_cn&edition=full","pubTime":"2025-05-05 22:06","pubTimestamp":1746453967,"startTime":"0","endTime":"0","summary":"GAAP每股收益为0.03美元。","market":"us","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1289314.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["TGTX"],"gpt_icon":0},{"id":"2533801835","title":"生物制药公司TG Therapeutics(TGTX.US)股价大跌 Q1盈利不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2533801835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533801835?lang=zh_cn&edition=full","pubTime":"2025-05-05 22:00","pubTimestamp":1746453625,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周一美股盘初,截至发稿,生物制药公司TG Therapeutics(TGTX.US)股价大跌近15%。消息面上,TG Therapeutics公布的2025年第一季度财报显示,Q1营收为1.21亿美元,同比增长90.4%,较分析师预期高300万美元;GAAP每股收益为0.03美元,较分析师预期低0.14美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LENZ","TGTX","TG","BK4007","BK4588","BK4090","BK4153","BK4139"],"gpt_icon":0},{"id":"2533532655","title":"Tg Therapeutics, Inc.盘中异动 早盘大幅跳水7.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533532655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533532655?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:31","pubTimestamp":1746451884,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时31分,Tg Therapeutics, Inc.股票出现异动,股价急速下跌7.80%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.05%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Scisparc Ltd.涨幅较大,Nucana Plc、Scisparc Ltd.、Aptevo Therapeutics Inc.较为活跃,换手率分别为664.63%、246.55%、42.66%,振幅较大的相关个股有Radiopharm Theranostics Limited、Protagenic Therapeutics, Inc.、Dianthus Therapeutics, Inc.,振幅分别为8.19%、7.66%、7.60%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213124a472d755&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213124a472d755&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","LENZ","BK4139","TGTX","BK4007"],"gpt_icon":0},{"id":"2532879124","title":"Tg Therapeutics, Inc.盘中异动 临近收盘急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532879124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532879124?lang=zh_cn&edition=full","pubTime":"2025-05-03 03:35","pubTimestamp":1746214530,"startTime":"0","endTime":"0","summary":"北京时间2025年05月03日03时35分,Tg Therapeutics, Inc.股票出现异动,股价急速下挫5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。其相关个股中,Polyrizon Ltd.、Celularity Inc C/Wts 16/07/2026 、Impact Biomedical, Inc.涨幅较大,Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃,换手率分别为1501.83%、846.64%、813.92%,振幅较大的相关个股有Polyrizon Ltd.、Celularity Inc C/Wts 16/07/2026 、Impact Biomedical, Inc.,振幅分别为267.88%、175.97%、119.72%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050303353194eaef7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050303353194eaef7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","TGTX","BK4007","BK4588","BK4139"],"gpt_icon":0},{"id":"2529382886","title":"Tg Therapeutics, Inc.盘中异动 早盘大幅上涨5.00%报39.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529382886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529382886?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:30","pubTimestamp":1745418613,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时30分,Tg Therapeutics, Inc.股票出现波动,股价大幅拉升5.00%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.63%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Ensysce Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大,Ensysce Biosciences, Inc.、Silexion Therapeutics Corp、Plus Therapeutics, Inc.较为活跃,换手率分别为5276.52%、479.57%、69.69%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Ensysce Biosciences, Inc.、Silexion Therapeutics Corp,振幅分别为223.08%、74.87%、69.86%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的商业化生物制药公司,专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423223013aa2c790b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423223013aa2c790b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","BK4139","BK4588","LENZ","BK4007","BK4585"],"gpt_icon":0},{"id":"2518744086","title":"Tg Therapeutics, Inc.2024财年实现净利润23.38百万美元,同比增加84.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518744086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518744086?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449668,"startTime":"0","endTime":"0","summary":"3月9日,Tg Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为23.38百万美元,同比增加84.53%;其中营业收入为3.29亿美元,同比增加40.60%,每股基本收益为0.16美元。机构评级:截至2025年3月9日,当前有6家机构对Tg Therapeutics, Inc.目标价做出预测,其中目标均价为42.83美元,其中最低目标价为10.00美元,最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230a266b3d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230a266b3d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TGTX","LENZ"],"gpt_icon":0},{"id":"2517162677","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.04%报36.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162677?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:04","pubTimestamp":1741277052,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时04分,Tg Therapeutics, Inc.股票出现波动,股价快速拉升5.04%。截至发稿,该股报36.88美元/股,成交量108.177万股,换手率0.69%,振幅6.61%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000412989ec607&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000412989ec607&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4585","TGTX","BK4588"],"gpt_icon":0},{"id":"2516711677","title":"Tg Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516711677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516711677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:37","pubTimestamp":1741099069,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时37分,Tg Therapeutics, Inc.股票出现波动,股价急速拉升5.00%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1090.78%、1079.98%、427.26%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Pliant Therapeutics, Inc.,振幅分别为23.30%、22.25%、14.49%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223749abe7f1dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223749abe7f1dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","TGTX","LENZ","BK4585"],"gpt_icon":0},{"id":"1131727124","title":"TG Therapeutics 2024年第四季度GAAP每股收益$0.15,与预期一致,销售额$108.19M超$99.95M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1131727124","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131727124?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:13","pubTimestamp":1741004021,"startTime":"0","endTime":"0","summary":"TG Therapeutics公布季度每股收益为$0.15,符合分析师的一致预期。公司本季度销售额为$108.19百万,超过分析师预期的$99.95百万,超出8.24%。与去年同期的$43.97百万销售额相比,这是一个146.04%的增长。以上内容来自Benzinga Earnings专栏,原文如下:TG $Therapeutics$ reported quarterly earnings of $0.15 per share which met the analyst consensus estimate. This is a 250 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $108.19 million which beat the analyst consensus estimate of $99.95 million by 8.24 percent. This is a 146.04","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TGTX","TG"],"gpt_icon":0},{"id":"2516301606","title":"Tg Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301606?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:50","pubTimestamp":1740775803,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时50分,Tg Therapeutics, Inc.股票出现异动,股价急速拉升5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045003abe13d94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045003abe13d94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LENZ","TGTX","BK4588","BK4139"],"gpt_icon":0},{"id":"2514703346","title":"Tg Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703346?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:22","pubTimestamp":1740428567,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时22分,Tg Therapeutics, Inc.股票出现波动,股价大幅跳水5.12%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为327.09%、142.18%、41.18%,振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ,振幅分别为176.22%、162.04%、81.92%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504224798913a0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504224798913a0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","TGTX","LENZ"],"gpt_icon":0},{"id":"2508997936","title":"Tg Therapeutics, Inc.盘中异动 临近收盘股价大跌5.01%报31.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508997936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508997936?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:54","pubTimestamp":1738356887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时54分,Tg Therapeutics, Inc.股票出现异动,股价快速跳水5.01%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045447a2358435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201045447a2358435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","TGTX","LENZ","BK4588","BK4139"],"gpt_icon":0},{"id":"2506309359","title":"Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506309359?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:24","pubTimestamp":1737991499,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时24分,Tg Therapeutics, Inc.股票出现波动,股价急速拉升5.05%。Tg Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.32%。其相关个股中,Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大,Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃,换手率分别为1801.77%、202.36%、197.33%,振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Dogwood Therapeutics, Inc.,振幅分别为85.35%、65.16%、61.84%。Tg Therapeutics, Inc.公司简介:TG Therapeutics Inc 是一家完全整合的,商业阶段生物制药公司,专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232459961241f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232459961241f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TGTX","BK4585","BK4139","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tgtherapeutics.com","stockEarnings":[{"period":"1week","weight":0.066},{"period":"1month","weight":0.0542},{"period":"3month","weight":-0.0065},{"period":"6month","weight":0.3027},{"period":"1year","weight":0.7847},{"period":"ytd","weight":0.2611}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.0615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司,专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外,TG还获得了美国食品药品监督管理局(FDA)的BRIUMVI(ublituximab-xiiy)批准,用于治疗成人复发性多发性硬化症(RMS)患者,包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.05545},{"month":2,"riseRate":0.666667,"avgChangeRate":0.075535},{"month":3,"riseRate":0.666667,"avgChangeRate":0.113076},{"month":4,"riseRate":0.416667,"avgChangeRate":0.02059},{"month":5,"riseRate":0.5,"avgChangeRate":-0.003449},{"month":6,"riseRate":0.538462,"avgChangeRate":0.05525},{"month":7,"riseRate":0.461538,"avgChangeRate":0.003412},{"month":8,"riseRate":0.583333,"avgChangeRate":-0.018713},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.054488},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.063094},{"month":11,"riseRate":0.916667,"avgChangeRate":0.190893},{"month":12,"riseRate":0.5,"avgChangeRate":0.112059}],"exchange":"NASDAQ","name":"TG Therapeutics Inc.","nameEN":"TG Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TG Therapeutics Inc.,TGTX,TG Therapeutics Inc.股票,TG Therapeutics Inc.股票老虎,TG Therapeutics Inc.股票老虎国际,TG Therapeutics Inc.行情,TG Therapeutics Inc.股票行情,TG Therapeutics Inc.股价,TG Therapeutics Inc.股市,TG Therapeutics Inc.股票价格,TG Therapeutics Inc.股票交易,TG Therapeutics Inc.股票购买,TG Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}